OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COPD and multimorbidity: recognising and addressing a syndemic occurrence
Leonardo M. Fabbri, Bartolomé R. Celli, Álvar Agustí, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 1020-1034
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Lung-function trajectories: relevance and implementation in clinical practice
Erik Melén, Rosa Faner, James P. Allinson, et al.
The Lancet (2024) Vol. 403, Iss. 10435, pp. 1494-1503
Open Access | Times Cited: 38

Pulmonary hypertension associated with lung diseases
Oksana A. Shlobin, Yochai Adir, Joan Albert Barberá, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401200-2401200
Open Access | Times Cited: 15

Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis
Edoardo Pirera, Domenico Di Raimondo, Lucio D’Anna, et al.
European Journal of Internal Medicine (2025)
Open Access | Times Cited: 2

Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding
Shawn D. Aaron, María Montes de, Bartolomé R. Celli, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 8, pp. 928-937
Closed Access | Times Cited: 11

Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
Yurong Xiang, X. Luo
International Journal of COPD (2024) Vol. Volume 19, pp. 567-578
Open Access | Times Cited: 11

Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review
Dave Singh, MeiLan K. Han, Nathaniel M. Hawkins, et al.
Advances in Therapy (2024) Vol. 41, Iss. 6, pp. 2151-2167
Open Access | Times Cited: 9

MACE in COPD: addressing cardiopulmonary risk
John R. Hurst, Chris P Gale, John R. Hurst, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 5, pp. 345-348
Open Access | Times Cited: 8

Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins
Gilda Varricchi, Remo Poto
European Journal of Internal Medicine (2024) Vol. 125, pp. 28-31
Open Access | Times Cited: 7

Early Life Exposures and the Development of COPD Across the Life Course
Nicholas S Hopkinson, Andrew Bush, James P. Allinson, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 5, pp. 572-580
Closed Access | Times Cited: 6

Neutrophil extracellular traps and their implications in airway inflammatory diseases
Nanxia Xuan, Jie Zhao, Zhi-Ying Kang, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 5

Current pharmacotherapy of COPD
Maarten van den Berge, Bianca Beghè, Lies Lahousse, et al.
European Respiratory Society eBooks (2024)
Closed Access | Times Cited: 5

A deep insight into ferroptosis in lung disease: facts and perspectives
Fan Zhang, Xiang Yu, Qiao Ma, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5

Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
Shyamali C. Dharmage, Rosa Faner, Àlvar Agustí
Respirology (2024) Vol. 29, Iss. 7, pp. 551-562
Open Access | Times Cited: 5

Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
Wenying Lu, Rebekka Aarsand, Kerstin Schotte, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5

Effects of population aging on quality of life and disease burden: a population-based study
Jun‐Yan Xi, Boheng Liang, Wangjian Zhang, et al.
Global Health Research and Policy (2025) Vol. 10, Iss. 1
Open Access

Cardiovascular risk assessment in patients with COPD: reduce, reuse and recycle
Miguel Divo, Ciro Casanova, Víctor Pinto-Plata
European Respiratory Journal (2025) Vol. 65, Iss. 2, pp. 2402103-2402103
Closed Access

Präklinische Versorgung der akuten COPD-Exazerbation
Achim Grünewaldt, Klaas Franzen
Notfallmedizin up2date (2025) Vol. 20, Iss. 01, pp. 45-60
Closed Access

Nebulized mesenchymal stem cell-derived exosomes attenuate airway inflammation in a rat model of chronic obstructive pulmonary disease
Min Wang, Yuxin Hao, Wei He, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104933-104933
Closed Access

Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes
Chongyang Zhao, Gang Wang, Li Zhang, et al.
Respiratory Medicine (2025) Vol. 240, pp. 108024-108024
Closed Access

Page 1 - Next Page

Scroll to top